Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009218
Chunk: 91

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 91
---
 authority to appoint any person on behalf of                                                       
 any holder of D Deferred Shares to enter into an agreement to transfer such D Deferred Shares to such other person (whether or not an 
 officer of the Company) as the Board may determine to act as the custodian thereof; and/or                                            |

| 72 |

| (B) | The Board may convene a general meeting of the Company in accordance with Section                                                            
 694 of the Act, for the purpose of considering and, if thought fit, passing a resolution to authorise the terms of a contract for the        
 purchase by the Company of any or all of the D Deferred Shares. The terms of such contract shall provide for payment in full of the purchase 
 price upon completion and may require the holders of the D Deferred Shares concerned to sell such shares for a price not exceeding 1 penny   
 for all the D Deferred Shares so purchased. If such a resolution is passed and the Company is in all other respects able and willing to      
 purchase the D Deferred Shares to which the contract relates in accordance with Sections 690 to 708 of the Act, the Company shall have       
 irrevocable authority to appoint any person: (i) to execute such contract on behalf of each of the holders of the relevant D Deferred        
 Shares; (ii) to execute a stock transfer form (or forms) sufficient in every respect to transfer to the Company the legal title to the       
 D Deferred Shares that are the subject of such contract, and (iii) to receive at completion the purchase price on behalf of the holders      
 of the D Deferred Shares. From the time that such resolution is passed, the holders of the D Deferred Shares that are the subject of such    
 contract shall hold such shares as bare trustee for the Company.                                                                             |

| 146.3 | -A | Subject to the Act, the Company may, at its option, cancel D Deferred Shares by way of a reduction 
 of capital for no consideration; and/or                                                            |

| (B) | Pending any such transfer and/or purchase and/or cancellation, the Company may              
 retain any share certificate that may be issued in respect of any of the D Deferred Shares. |

| 147 | FORUM SELECTION |

| 147.1 | Unless the Company consents in writing to the selection of an alternative forum, the courts of England 
 and Wales shall, to the fullest extent permitted by law, be the sole and exclusive forum for:          |

| (A) | any derivative action or proceeding brought on behalf of the